Turning a corner: Private market posts best month in yearsCore private market metrics suggest positive momentum is brewing and investor sentiment is improving
Turning a corner: Private market posts best month in years
Trading
Data
Solutions
Insights
About
Intarcia is a biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 9/15/2016 | Series EE | $475.68MM raised | $XXX.XX | $XXX.XX |
| 7/4/2014 | Series DD | $200MM raised | $XXX.XX | $XXX.XX |
| 11/15/2012 | Series CC | $210MM raised | $XXX.XX | $XXX.XX |
| 1/14/2010 | Series BB-3 | $7.87MM raised | $XXX.XX | $XXX.XX |
| 4/28/2008 | Series BB-2 | $24.99MM raised | $XXX.XX | $XXX.XX |
| 3/9/2007 | Series BB-1 | $23.84MM raised | $XXX.XX | $XXX.XX |
| 12/1/2004 | Series AA | $19.08MM raised | $XXX.XX | $XXX.XX |
